Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SAXAGLIPTIN Cause Blood glucose increased? 152 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Blood glucose increased have been filed in association with SAXAGLIPTIN (SAXAGLIPTIN). This represents 6.2% of all adverse event reports for SAXAGLIPTIN.

152
Reports of Blood glucose increased with SAXAGLIPTIN
6.2%
of all SAXAGLIPTIN reports
3
Deaths
23
Hospitalizations

How Dangerous Is Blood glucose increased From SAXAGLIPTIN?

Of the 152 reports, 3 (2.0%) resulted in death, 23 (15.1%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Blood glucose increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SAXAGLIPTIN. However, 152 reports have been filed with the FAERS database.

What Other Side Effects Does SAXAGLIPTIN Cause?

Cardiac failure congestive (393) Cardiac failure (360) Cardiovascular disorder (159) Weight decreased (124) Death (115) Nausea (113) Drug ineffective (105) Dizziness (91) Drug dose omission (89) Pancreatitis (80)

What Other Drugs Cause Blood glucose increased?

INSULIN LISPRO (31,969) INSULIN GLARGINE (19,234) DULAGLUTIDE (9,119) INSULIN HUMAN (8,704) INSULIN ASPART (4,743) METFORMIN (4,038) EXENATIDE (3,363) INSULIN DEGLUDEC (2,644) SEMAGLUTIDE (2,240) TIRZEPATIDE (2,240)

Which SAXAGLIPTIN Alternatives Have Lower Blood glucose increased Risk?

SAXAGLIPTIN vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER SAXAGLIPTIN vs SCOPOLAMINE SAXAGLIPTIN vs SCOPOLAMINE HYDROBROMIDE SAXAGLIPTIN vs SEBELIPASE ALFA SAXAGLIPTIN vs SECNIDAZOLE

Related Pages

SAXAGLIPTIN Full Profile All Blood glucose increased Reports All Drugs Causing Blood glucose increased SAXAGLIPTIN Demographics